Get the Stockscreener App
8.00
11.01%
-0.99
After Hours:
7.91
-0.09
-1.12%
Nutriband Inc stock is traded at $8.00, with a volume of 408.53K.
It is down -11.01% in the last 24 hours and up +65.63% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$8.99
Open:
$9.09
24h Volume:
408.53K
Relative Volume:
8.07
Market Cap:
$97.25M
Revenue:
$1.80M
Net Income/Loss:
$-8.08M
P/E Ratio:
-3.0467
EPS:
-2.6258
Net Cash Flow:
$-4.36M
1W Performance:
-1.60%
1M Performance:
+65.63%
6M Performance:
+110.53%
1Y Performance:
+11.58%
1-Day Range:
$7.10
$9.1851
1-Week Range:
$6.56
$9.1851
52-Week Range:
$2.80
$9.1851
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
8.00 | 109.28M | 1.80M | -8.08M | -4.36M | -2.6258 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Nutriband Adds Robert J. O’Neill to Advisory Board as AVERSA Fentanyl Advances - citybiz
Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert - PRLog
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board - The Manila Times
Form 8K Nutriband Inc. For: 23 September - Investing.com India
NutriBand warrants to expire and be removed from Nasdaq listing on Sept. 30, 2026 - TradingView
910,904 rights to buy shares expire Sept. 30; Nutriband won't extend them - Stock Titan
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing - The Manila Times
Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB) - WBOC TV
(NTRB) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Nutriband (NTRB) Climbs 3.23% to $7.04 as Shares Press Toward Upper RangeBearish Sentiment - dars.gov.et
NutriBand (NTRB) CEO controls 14.2% of the company through founder shares and options - Stock Titan
Nutriband CEO to Speak at Nasdaq Biotech Summit, Highlighting Abuse-Deterrent Patch Technology - citybuzz -
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit - The Manila Times
Nutriband CEO Gareth Sheridan to Attend Inaugural Nasdaq LaB Biotech Summit - Quiver Quantitative
NutriBand (NASDAQ: NTRB) Posts $437,514 Revenue Amid Declining Customer Demand - Kalkine Media
Nutriband Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch - citybuzz -
NTRB Looks 112.1% Overvalued on GF Value™ - GuruFocus
Nutriband Receives USPTO Notice of Publication of - GlobeNewswire
(NTRB) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Nutriband Stock Price Forecast. Should You Buy NTRB? - StockInvest.us
NutriBand Revenue Falls 30% in Q2 as Cost Cuts Narrow Net Loss - Minichart
NutriBand Inc. 3Q 2026: Revenue $437514 EPS $(0.07) — 10-Q Summary - TradingView
NutriBand (NTRB) cuts cash burn as sales slip - Stock Titan
NTRB Q2 2026 Earnings: Loss Narrows to $0.08 Per Share, a 95.85% Positive Surprise Over ConsensusROIC Trend Report - dars.gov.et
Nutriband Inc (NTRB) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Veeva Systems Inc. Class A (VEEV) Peer Comparison – Compare with Others - valueresearchonline.com
Nutriband Inc (NTRB) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Nutriband Inc. Warrant (NTRBW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Nutriband Inc. Warrant (NTRBW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Nutriband (NTRB) Financial Update: Profit Per Share Surpasses Its Benchmark; Stock Move - vinanet.vn
Nutriband (NTRB) Financial Update: Profit Per Share Surpasses Its Benchmark; Stock Move: Shares Move Higher 22.31%Profit Margin Analysis - dars.gov.et
Nutriband (NTRBW) Session: Ends Higher by 25.06% at $0.50; Market Levels: the Price Remains Bounded by the Supplied Support and Resistance at the CloseHagopian Line - dars.gov.et
Nutriband (NTRBW) Latest: Ends Higher by 25.06% at $0.50 in Latest Trading; Current Setup: Traders Can Monitor the $0.47-$0.53 Range at the CloseFactor Timing - vinanet.vn
Nutriband (NTRB) Earnings Report: EPS Clears the Reported Estimate on the Day; Price Move: The Stock Records a 7.46% Increase in Latest TradingEarnings Whisper Number - vinanet.vn
Nutriband (NTRBW) Daily Review: Closes Nearly Flat at $0.35; Current Setup: the Current Price Sits Inside the Supplied Technical Range on the DayLeveraged ETF Flow - dars.gov.et
Nutriband Inc. (NTRB) Advances 3.45% to $3.30, Testing Key Resistance at $3.46Buy Signal Reports - vinanet.vn
Nutriband Warrant (NTRBW) Holds Steady at $0.35 as Tight Trading Range PersistsAndrews Pitchfork - vinanet.vn
Nutriband (NTRB) Holds Near $3.17 as Traders Eye Key Support and Resistance LevelsETF Liquidity - vinanet.vn
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - The Manila Times
Nutriband Co-Founder Gareth Sheridan Set for CEO Spotlight - Stock Titan
NTRB Q2 2026 Earnings: Loss Narrowed Far Beyond Expectations, Stock Gains 0.96%Negative Surprise Momentum - vinanet.vn
Nutriband Inc (NTRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nutriband Inc (NTRB) Stock News Today - TradingKey
NTRB Q2 2026 Earnings: 95.85% EPS Surprise as Loss Narrows Sharply vs. EstimateEarnings Decline Risk - dars.gov.et
NTRB|Nutriband Inc|Price:3.060|Chg%:+0.080 - TradingKey
Nutriband Inc (NTRB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nutriband Inc (NTRB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nutriband Inc (NTRB) Balance Sheet - TradingKey
Nutriband Inc (NTRB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nutriband Inc (NTRB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nutriband Inc (NTRB) Institutional Confidence - TradingKey
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):